Background Urine uric acid (UUA) has been implicated in the pathogenesis of diabetic nephropathy via its effect on tubular cells. We hypothesized that the UUA level would be higher in adolescents with type 1 diabetes (T1D) than in those without T1D. We also hypothesized that UUA and fractional uric acid excretion (FeUA) would be higher in adolescents with T1D and hyperfiltration [estimated glomerular filtration rate (eGFR) ≥141 mL/min/1.73 m 2 ] than in those without hyperfiltration. Methods The UUA concentration was determined and FeUA calculated in adolescents with (n = 239) and without T1D (n = 75). The eGFR was calculated using the Zappitelli equation based on serum creatinine and cystatin C concentrations. Results Compared to the non-diabetic adolescents enrolled in the study, those with T1D had a higher eGFR (mean ± standard deviation: 120 ± 22 vs. 112 ± 16 mL/min/1.73 m 2 ; p = 0.0006), lower urine pH (6.2 ± 0.8 vs. 6.5 ± 1.0; p = 0.01), and higher UUA (37.7 ± 18.6 vs. 32.8 ± 18.1 mg/dL; p = 0. Conclusions The adolescents with T1D enrolled in the study had higher eGFR, higher UUA and more acidic urine than the non-diabetic controls, which may have increased their risk of UUA crystallization. Adolescents with T1D and hyperfiltration had higher FeUA than those without hyperfiltration. These hypothesis-generating observations may suggest a potential pathophysiologic association between uricosuria and hyperfiltration.
Abstract
Background Urine uric acid (UUA) has been implicated in the pathogenesis of diabetic nephropathy via its effect on tubular cells. We hypothesized that the UUA level would be higher in adolescents with type 1 diabetes (T1D) than in those without T1D. We also hypothesized that UUA and fractional uric acid excretion (FeUA) would be higher in adolescents with T1D and hyperfiltration [estimated glomerular filtration rate (eGFR) ≥141 mL/min/1.73 m 2 ] than in those without hyperfiltration. Methods The UUA concentration was determined and FeUA calculated in adolescents with (n = 239) and without T1D (n = 75). The eGFR was calculated using the Zappitelli equation based on serum creatinine and cystatin C concentrations. Results Compared to the non-diabetic adolescents enrolled in the study, those with T1D had a higher eGFR (mean ± standard deviation: 120 ± 22 vs. 112 ± 16 mL/min/1.73 m 2 ; p = 0.0006), lower urine pH (6.2 ± 0.8 vs. 6.5 ± 1.0; p = 0.01), and higher UUA (37.7 ± 18.6 vs. 32.8 ± 18.1 mg/dL; p = 0.049) and FeUA (median [interquartile range]: 6.2 [4.3-8.7 ] vs. 5.2 [3.6-7 .0] %; p = 0.02). Among adolescents with T1D, those with hyperfiltration had higher median FeUA (8.6 [5.2-9.9] vs. 6.0 [4.2-8.3 ] %; p = 0.02) than those without hyperfiltration. Conclusions The adolescents with T1D enrolled in the study had higher eGFR, higher UUA and more acidic urine than the non-diabetic controls, which may have increased their risk of UUA crystallization. Adolescents with T1D and
Introduction
Diabetic nephropathy (DN) is the single most important cause of end-stage renal disease in the Western world [1] [2] [3] . Early manifestations of DN, which included microalbuminuria and hyperfiltration, are present in adolescents and young adults with type 1 diabetes (T1D). Hyperfiltration is an early phenotype of DN that is thought to precede microalbuminuria and which is associated with cardiovascular disease and progression of DN [4] . The mechanisms responsible for hyperfiltration in diabetes are not completely understood but are likely due to a combination of glomerular hemodynamic, vasoactive, and metabolic factors that together increase intraglomerular pressure and flow, leading to structural changes including mesangial expansion and glomerular basement membrane thickening [5, 6] . Previous studies have for the most part supported a role for hyperfiltration in the initiation and progression of DN in T1D [7] , but precisely how hyperfiltration is associated with DN progression in T1D remains poorly understood.
Serum uric acid (SUA) is a recognized risk factor for DN in T1D [8] , but emerging mechanistic data also support urine uric acid (UUA) as an important mediator of DN via its harmful effects on tubular cells [9, 10] . Under acidic conditions UUA precipitates and causes crystallization which can lead to tubular injury. Furthermore, there is a report that elevated concentrations of soluble UUA may also cause epithelial mesenchymal changes in tubular cells [11] . In diabetes, glycosuria leads to elevated levels of UUA through the uricosuric effect, i.e., glucose increases the excretion of uric acid in urine, but it is unclear whether hyperfiltration can increase fractional uric acid excretion (FeUA). Individuals with diabetes are also thought to be relatively volume depleted from glycosuria [12] , which could lead to increased proximal tubular absorption of sodium and bicarbonate and consequent acidic urine. It is, however, unknown whether the urine of adolescents with T1D is more acidic than that of their non-diabetic counterparts in the absence of ketoacidosis. Accordingly, in the study reported here we examined urine pH, UUA, and FeUA in adolescents with and without T1D. We hypothesized that adolescents with T1D would have more acidic urine and higher UUA than their non-diabetic counterparts. Second, we examined uricosuria in adolescents with T1D with and without hyperfiltration. We hypothesized that hyperfiltration would be associated with elevated FeUA in adolescents with T1D.
Materials and methods
The Determinants of Macrovascular Disease in Adolescents with Type 1 Diabetes study was initiated to investigate atherosclerotic disease risk in youth with T1D [13, 14] . Between 2008 and 2010, 300 subjects with TD1 ranging in age from 12 to 19 years were enrolled in the study together with 100 non-diabetic controls of similar age [13] . Study participants with T1D were diagnosed by islet cell antibody or by provider clinical diagnosis, had diabetes duration of >5 years at entry into the study, and received care at the Barbara Davis Center for Childhood Diabetes. Control subjects were recruited from friends of the study subjects as well as from campus and community advertisements. No siblings or first-degree relatives of patients with T1D were included. Subjects were excluded from entry into the study for diabetes of any other type or for a history of abnormal cardiac anatomy or arrhythmia that would preclude the subject from vascular function measurements. Participants with (n = 239) and without (n = 75) T1D and data on UUA were included in our analyses. The study was approved by the Colorado Multiple Institution Review Board, and informed consent and assent (for subjects aged <18 years) were obtained from all subjects.
Resting blood pressure measurements were obtained for all participants. Briefly, after the subject had rested in a supine position for a minimum of 5 min, blood pressure measurements were obtained using a Dynapulse 5200A Pathway Blood Pressure Monitor (Pulse Metric, San Diego, CA) and the average of three measurements recorded. Height was measured to the nearest 0.1 cm with shoes removed using a wallmounted stadiometer, and weight was measured to the nearest 0.1 kg using a Detecto scale (Detecto, Webb City, MI).
All subjects fasted overnight (≥8 h) prior to blood and urine collection. Urine samples were centrifuged at 3900 rpm for 10 min at 4°C, and the urine pH was measured from the collected supernatant using the Accumet basic AB 15 plus pH Meter (Thermo Fisher Scientific, Hudson, NH). UUA and SUA were evaluated using a QuantiChrom TM Uric Acid kit assay (DIUA-250) with quantitative colorimetric uric acid determination at 590 nm (BioAssay Systems LLC, Hayward, CA). UUA concentrations were measured once the urine pH was buffered to ≥7.0 with sodium bicarbonate. FeUA was calculated as: 100 × [(UUA × serum creatinine)/(SUA × urine creatinine)]. Urine creatinine and albumin concentrations were measured by radioimmunoassay (Diagnostic Products Corp., Los Angeles, CA) and the urine albumin to creatinine (ACR) ratio calculated. Serum creatinine was measured at the University of Colorado Hospital clinical lab using commercially available assays [15] . Cystatin C was measured using the commercially available Dade-Behring assay following package insert instructions on a BNII instrument. Estimated glomerular filtration rate (eGFR) (mL/min/1.73 m ] [16] [17] [18] . Hyperfiltration is typically defined as 2 standard deviations above the mean GFR in healthy participants, and we defined hyperfiltration a priori as an eGFR of ≥141 mL/min/ 1.73 m 2 , which according to the National Health and Nutrition Examination Survey (NHANES) represents the eGFR at the 95th percentile for the non-diabetic controls in our cohort and at the 99th percentile for healthy adolescents [7, 18] . As a sensitivity analysis we ran similar models with eGFR calculated by the [16] . Glycated hemoglobin (HbA1c) was measured on the DCA Advantage HbA1c Analyzer (Siemens, Princeton, NJ) at the main clinical laboratory of Children's Hospital Colorado.
Statistical analysis
Analyses were performed in SAS (ver. 9.4 or higher; SAS Institute, Cary, NC). Demographic and clinical characteristics among adolescents with and without T1D and among T1D adolescents with and without hyperfiltration were compared using Student's t test for normally distributed continuous variables, Wilcoxon's test for non-normally continuous variables (e.g., ACR and FeUA), and the χ 2 test for categorical variables.
Generalized linear regression models were employed to evaluate the associations between glucose, HbA1c, eGFR, and FeUA, as well as the differences in FeUA between participants with and without hyperfiltration adjusted for ACR and HbA1c. In the generalized linear regression model FeUA was natural log-transformed due to positively skewed distribution. Significance was based on an α-level of 0.05.
Results
Adolescents with T1D had greater FeUA and more acidic urine than the controls Adolescents with T1D had lower SUA than their non-diabetic peers (Table 1 ), but they had higher eGFR, a more acidic urine, and greater UUA and FeUA (Table 1) . UUA concentration is standardly measured in a buffered urine pH of ≥7.0 as UUA solubility depends on urine pH. As a sensitivity analysis, we also measured UUA concentration in the native urine pH and adjusted for the urine pH in a generalized linear regression model. The pH-adjusted UUA remained significantly greater in adolescents with T1D compared to their non- Glucose and eGFR correlated with FeUA in adolescents with T1D
In adolescents with T1D, concurrent fasting glucose (β ± standard error: 0.01 ± 0.00; p = 0.01) but not HbA1c (β0.02 ± 0.15; p = 0.91) was associated with FeUA. Furthermore, eGFR was positively associated with FeUA ( Fig. 1) . All data in table are presented as the mean ± standard deviation (SD) or as the median with the interquartile range (IQR) in square brackets, unless otherwise specified T1D, Type 1 diabetes; BMI, body mass index; HbA1c, hemoglobin A1c; eGFR, estimated glomerular filtration rate; ACR, albumin-to-creatinine ratio; SUA, serum uric acid; UUA, urine uric acid; FeUA, fractional excretion of uric acid; SBP, systolic blood pressure; DBP, diastolic blood pressure
Discussion
Adolescents with T1D had higher eGFR, more acidic urine and higher FeUA than their non-diabetic counterparts. Furthermore, adolescents with T1D and hyperfiltration had higher FeUA compared to their peers without hyperfiltration. While our observations are cross-sectional and cannot imply causality, they do support our hypothesis that adolescents with T1D and renal hyperfiltration may be at increased risk of UUA precipitation and crystallization due to relative uricosuria in the setting of acidic urine (Fig. 2) . T1D in adolescents and young adults is commonly accompanied by hyperfiltration [19] . Hyperfiltration is associated with increased intraglomerular pressure and may promote the development of diabetic nephropathy by unclear mechanisms [20, 21] . While hyperfiltration is associated with progression of DN in some patients with T1D [4] , the risk of nephropathy is also affected by a number of other important factors, including blood pressure, arterial stiffness, inflammation and glycemic control [7] . The results of our study demonstrate an association between hyperfiltration and elevated FeUA in adolescents with T1D. Elevated UUA has been associated with tubular nephropathy, especially in the setting of acidic urine which promotes UUA precipitation and crystallization [22] . Urine pH in the normal population tends to average 6.5 (normal range 5.0-8.5), and it has been shown to be very stable over time if stored at −20°C or lower [23] . The solubility of UUA depends on urine pH, and for that reason urine pH is typically increased to 7.0 or above prior to measurement of the concentration of UUA. We also observed lower urinary pH values in adolescents with T1D. The cause of the urinary acidification is unclear, but it may be related to a relative volume depletion in diabetes in the setting of glycosuria with consequent proximal absorption of sodium and bicarbonate.
Diabetic tubular nephropathy is associated with basement membrane thickening, tubular hypertrophy, epithelial-mesenchymal transition, glycogen accumulation, and interstitial inflammation [24] . Although glomerular changes have received significantly more attention from researchers and clinicians than tubulointerstitial changes in diabetes, tubular injury is known to be more strongly associated with renal function than glomerular injury [9, 25] . In fact, tubular damage may be induced earlier than glomerular injury in the course of diabetic nephropathy [10] . Animal studies have demonstrated that blocking uric acid production protects the kidney from tubulointerstitial injury, which suggests a causal role for uric acid in the development of diabetic tubular injury [26] . All data in table are presented as the mean ± SD or as the median with the IQR in square brackets, unless otherwise specified T1D, Type 1 diabetes; BMI, body mass index; HbA1c, hemoglobin A1c; eGFR, estimated glomerular filtration rate; ACR, albumin-to-creatinine ratio; SUA, serum uric acid; FeUA, fractional excretion of uric acid; SBP, systolic blood pressure; DBP, diastolic blood pressure a Of the 239 study subjects, the 232 individuals for whom T1D data on the eGFR by the Zappitelli equation were available were included for analysis in this table Furthermore, allopurinol has been shown to attenuate the diabetic tubular injury associated with the KK-A(y)/Ta mouse model [27] , and the PERL (Preventing Early Renal Function Loss in Diabetes) study is currently investigating the effects of lowering uric acid levels using allopurinol on slowing down the decline in GFR in adults with T1D [28] . Moreover, it has recently been shown that UUA promotes apoptosis in human proximal tubular cells by oxidative stress and activation of NADPH oxidase NOX4 [29] . Glucosuria is a recognized cause of elevated urate load in T1D [12] . Herein, we report for the first time that hyperfiltration may also be associated with elevated FeUA in adolescents with T1D. The increased urate load in T1D may lead to increased intratubular uric acid concentrations that form crystals in the setting of urinary acidification (Fig. 2) . Crystalline and non-crystalline UUA and monosodium urate activate tubular cells via both crystalline and non-crystalline effects, resulting in kidney injury [11, 30] . Crystalline uric acid likely stimulates inflammasome activation, Toll-like receptors, and chemotactic factors [31, 32] . Urate crystals have been reported to cause proximal tubular injury [30] . The observation that people with URAT1 mutations develop exercise-induced AKI with marked uricosuria suggests a crystal-dependent mechanism, since these individuals have a significantly reduced ability to reabsorb soluble uric acid and have an increased risk for uric acid kidney stones [33] . Potential non-crystalline effects may also be involved, including induction of oxidative stress, inhibition of cell proliferation, epithelial-mesenchymal cell transformation and stimulation of inflammatory pathways [11, [34] [35] [36] . Taken together, these findings suggest that UUA might directly act on the proximal tubular epithelial cells to cause inflammation and apoptosis in the diabetic kidney.
Limitations to our study include its observational and cross-sectional design which prevents determination of causality and direction, and whether the association holds true longitudinally. Furthermore, our study included more participants with T1D than without T1D to optimize power for the study's main hypotheses, and only a small number met our criteria for hyperfiltration. For these reasons, the data should be viewed strictly as hypothesis generating. Also, we used an estimate of GFR to assess renal function. However, Zappitelli's combined creatinine and cystatin C equation [17, 18, 37, 38] is considered to be state-of-the-art and has been shown to have a high accuracy in estimating GFR in children and adolescents with a GFR of >90 mL/min/1.73 m 2 [17, 18, 38] , and imprecision would bias our results towards the null. As a sensitivity analysis we ran similar models with GFR estimated by the Bouvet equation and obtained similar results.
In summary, based on our results, adolescents with T1D have higher eGFR and more acidic urine than their nondiabetic peers, which may increase their UUA concentration and decrease the urine solubility of uric acid, thereby predisposing to UUA precipitation and crystallization. Furthermore, the adolescents with T1D and hyperfiltration in our study had the highest FeUA. Uricosuria is an emerging risk factor for DN in animal models and could also explain how hyperfiltration contributes to the progression of DN. We submit this as a hypothesis to be proven or disproven. We also recognize that the hyperfiltration-uricosuria hypothesis does not exclude other important mechanisms contributing to the progression of DN in the setting of hyperfiltration. Understanding how hyperfiltration contributes to the progression of DN may direct development of therapies to prevent or delay GFR loss. Further studies are needed to examine the longitudinal relationships between hyperfiltration, UUA, and progression of DN, and to determine if the relationships between hyperfiltration, UUA, and DN hold true longitudinally.
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